Fulgent Genetics, Inc. FLGT AFS Securities
AFS Securities at other companies
Other financials
Where this comes from
Reported directly by Fulgent Genetics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent.
The official record: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →
Ask your AI about Fulgent Genetics, Inc.'s afs securities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Fulgent Genetics, Inc.'s AFS securities?
- Fulgent Genetics, Inc. (FLGT) reported AFS securities of $328.29M in Q1 2026.
- How has Fulgent Genetics, Inc.'s AFS securities changed year-over-year?
- Fulgent Genetics, Inc.'s AFS securities decreased by 33.6% year-over-year, from $494.11M to $328.29M.
- What is the long-term trend for Fulgent Genetics, Inc.'s AFS securities?
- Over 5 years (2020 to 2025), Fulgent Genetics, Inc.'s AFS securities has grown at a 22.8% compound annual growth rate (CAGR), from $132.5M to $369.27M.
- What does AFS securities mean?
- Debt securities classified as available-for-sale, measured at fair value with unrealized gains/losses in OCI rather than the income statement.